MyoKardia Inc (MYOK.OQ)
11 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|61||2016||Interim Non-Executive Chairman of the Board, Lead Independent Director|
|44||2013||President, Chief Executive Officer, Director|
|51||2017||Chief Operating Officer|
|38||2016||Senior Vice President - Finance and Corporate Development|
|54||2014||Senior Vice President - Nonclinical and Pharmaceutical Development|
- BRIEF-MyoKardia Inc reports Q3 loss per share $0.42
- BRIEF-MyoKardia expects to initiate next trial of MYK-491 in DCM patients by year-end
- BRIEF-MyoKardia announces pricing of public offering of common stock
- BRIEF-MyoKardia announces proposed public offering of common stock
- US STOCKS-Dow on track for 9th straight record close